Research Day 2022

REGISTRATION & PROGRAM

Please complete the Research Day Registration Form, which also includes the zoom information registration for Dr. Thompson's keynote presentation held from 0845-0945 MT.

REGISTRATION	research day registration
PROGRAM	research day Program
KEYNOTE PRESENTATION 0845-0945 MT  In-Person & Zoom	Dr. Peter J. Thompson, Assistant Professor, DEPARTMENT OF PHYSIOLOGY & PATHOPHYSIOLOGY, UNIVERSITY OF MANITOBA TITLE: Beta cell stress responses in Type 1 Diabetes: emerging lessons and therapeutic opportunities

Event details

The 2022 ADI Research Day will be held in-person on Friday, October 28, from 0815-1600 MT, at the Li Ka Shing Centre for Health Research Innovation in the Oborowsky Degner Seminar Hall (1-040 LKS) and the LKS Foyer.

The Keynote Speaker presentation by Dr. Thompson entitled "Beta cell stress responses in Type 1 Diabetes: emerging lessons and therapeutic opportunities" will be offered in hybrid format (zoom and in-person) from 0845-0945 MT. 

There are two Trainee poster sessions and two Trainee podium presentation sessions.

Trainee Awards will be announced Monday, October 31.

---

Peter J. Thompson, PhD

ADI is excited to announce this year's keynote speaker is Dr. Peter J. Thompson. Dr. Thompson is an Assistant Professor in the Department of Physiology & Pathophysiology at the University of Manitoba and a Principal Investigator in the Children’s Hospital Research Institute of Manitoba. He earned his BSc in molecular genetics (2007) and MSc in molecular biology (2010) at the University of Alberta, where his thesis characterized the roles of chromatin remodelling factors in mammalian development and the germline in the lab of Dr. Heather McDermid. He completed his PhD in medical genetics (2016) at the University of British Columbia in the lab of Dr. Matthew Lorincz, where he studied epigenetic mechanisms of gene regulation in embryonic stem cells. He moved into the fields of islet biology and diabetes during his postdoctoral fellowship at the University of California San Francisco (UCSF, 2016-2020), where his work discovered senescence as a new form of beta cell dysfunction in type 1 diabetes (T1D). He was funded by the Diabetes Research Connection, the Larry L. Hillblom Foundation and the Program for Breakthrough Biomedical Research at UCSF. He started his independent position at the University of Manitoba and Children’s Hospital Research Institute of Manitoba in 2020, where his research program explores beta cell stress responses and their crosstalk with the immune system in the pathogenesis of T1D with the goal of developing new therapies.